Hematopoietic Recovery after Anti-B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T Cell Therapy (CAR T), Idecabtagene Vicleucel (Ide-cel), for Relapsed/ Refractory Multiple Myeloma (RRMM)

Saved in:
Bibliographic Details
Published in:Transplantation and cellular therapy 2023-02, Vol.29 (2), p.S215-S216
Main Authors: Mohty, Razan, Drekolias, Dimitrios, Peres, Lauren, Freeman, Ciara, Castaneda, Omar, Faramand, Rawan G, Oswald, Laura, Reid, Kayla, De Avila, Gabe, Blue, Brandon Jamaal, Grajales, Ariel, Mohammed, Turab, Ochoa-Bayona, Jose, Shrewsbury, Alexandria M, Doyle, William, Gonzalez, Rebecca, Logue, Jennifer, Elmariah, Hany, Jain, Michael D, Liu, Hien, Brayer, Jason, Shain, Kenneth, Baz, Rachid, Alsina, Melissa, Nishihori, Taiga, Davila, Marco L., Locke, Frederick L., Hansen, Doris K
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2666-6367
2666-6367
DOI:10.1016/S2666-6367(23)00349-4